Immune checkpoint blockade therapy using anti-CTLA-4 reduced intratumoural Tregs in vivo (140) Tregs treated with anti-PD1 and anti-PD-L1 restored IFN-γ secretion in B16 melanoma (141). The gene discussed is PDCD1; the disease is melanoma.